Beta Bionics, Inc. (BBNX) vs CONMED Corporation (CNMD)
Beta Bionics, Inc. and CONMED Corporation are both Medical Devices companies. CONMED Corporation is the larger, with a market value of $1.4B against $1.2B — 1.2× the size. Beta Bionics, Inc. has negative trailing earnings, so its P/E is not meaningful; CONMED Corporation trades at 24.5×. Beta Bionics, Inc. grew revenue faster over the last twelve months: 52.5% against 3.42%. CONMED Corporation has the higher net margin (4.12% vs −61.3%) and the higher return on invested capital (3.75% vs −68.5%). Across the 17 metrics below, CONMED Corporation leads on 11 and Beta Bionics, Inc. on 6.
Valuation
Profitability
| Metric | BBNX | CNMD | Medical Devices median |
|---|---|---|---|
| Gross margin | 58.31% | 55.79% | 56.01% |
| Operating margin | (69.75%) | 8.04% | (15.03%) |
| Net margin | (61.32%) | 4.12% | (20.40%) |
| Free cash flow margin | (284.13%) | 9.80% | (7.24%) |
| Return on equity | (26.16%) | 5.53% | (15.32%) |
| Return on assets | (23.45%) | 2.44% | (19.72%) |
| Return on invested capital | (68.47%) | 3.75% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack